KERX - Keryx Biopharmaceuticals Incorporated

$2.91 0.11 | 3.93%
Today's Range: 2.79 - 2.93
KERX Avg. Daily Volume: 2,783,300
12/14/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 2.80
52 Week High 3.45
52 Week Low 0.09
Avg. Daily Vol. (Mil) 2.78
Beta (3 year) 4.03
Share Related Items
Mkt Cap (Mil) 156.75
Shares Out (Mil) 55.98
Float (Mil) 44.32
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.20
Current Ratio 5.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 11.70
Price/Sales 6.14
Price/Book 4.48
Price/Cash Flow 13.70
Per Share Data
Earnings 0.24
Sales 0.46
Book Value 0.62
Cash Flow 0.20
Business Summary
A biopharmaceutical company, focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer.
General Information
750 Lexington Avenue
New York, NY 10022
www.keryx.com
Industry : Drugs
Sector: Health Care
Employees: 17
CEO: Ron Bentsur
Short Interest
Current Month (Mil) 0.62
Previous Month (Mil) 0.72
Short Interest Ratio (Days) 0.70
Management Effectiveness
Return on Equity 32.40
Return on Assets 24.90
Return on Investments 32.40
Profitability
Gross Margin n.a.
EBIT Margin 38.30
Profit Margin 44.40
Latest KERX Headlines
More Financial News for KERX
Partner Headlines

Brokerage Partners

TheStreet Premium Services

All Services